MedTrace Logo

Noninvasive Continuous Blood Pressure Monitoring for Cesarean Delivery

NCT04752904 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2022-12-28

No results posted yet for this study

Summary

Noninvasive continuous blood pressure monitoring for preventing post-spinal hypotension during cesarean delivery: A randomized controlled trial

Conditions

Interventions

DEVICE

ClearSight System

Non-invasive, continuous blood pressure is monitored using ClearSight Sytem

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Sun-Kyung Park, M.D · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-27
Primary Completion
2022-10-26
Completion
2022-12-21

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04752904 on ClinicalTrials.gov